Evaluation of the Self-Administered Indicator Plaster Neuropad for the Diagnosis of Neuropathy in Diabetes
- Nicholas Tentolouris, MD,
- Vasilis Achtsidis, MD,
- Kyriaki Marinou, MD and
- Nicholas Katsilambros, MD
- From the 1st Department of Propaedeutic Medicine, Athens University Medical School, Laiko General Hospital, Athens, Greece
- Address correspondence and reprint requests to Nicholas Tentolouris, MD, 33 Lakonias St., 115 23, Athens, Greece. E-mail: ntentol{at}med.uoa.gr
Abstract
OBJECTIVE—To evaluate the inter-rater reliability between patient and health care provider of the indicator plaster neuropad (IPN) in the diagnosis of peripheral neuropathy and the feasibility of the IPN.
RESEARCH DESIGN AND METHODS—A total of 156 patients with diabetes were examined. At the same visit, the IPN was evaluated by the health care provider. Afterward, the IPN with written instructions for its use and evaluation for self-testing at home were provided together with a questionnaire asking for the easiness of the IPN.
RESULTS—Neuropathy was diagnosed in 56.9% of the participants by the health care provider. The k statistic to measure overall agreement between patient and health care provider of the IPN was very good: 0.88 (95% CI 0.85–0.91). The indicated instructions and the IPN were evaluated as easy by the patients.
CONCLUSIONS—The high degree of reliability and the easiness of the IPN suggest that it is proper for self-testing for the identification of peripheral neuropathy.
Footnotes
-
Published ahead of print at http://care.diabetesjournals.org on 19 November 2007. DOI: 10.2337/dc07-1942.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.
-
- Accepted November 12, 2007.
- Received October 7, 2007.
- DIABETES CARE
